Suchergebnisse - "Fedorinov, Denis S"

PubPharm (16)

1

Genotype-based chemotherapy for patients with gastrointestinal tumors : focus on oxaliplatin, irinotecan, and fluoropyrimidines

enthalten in: Drug metabolism and personalized therapy | 2022

von Fedorinov, D. | Lyadov, V. | Sychev, D.

2

Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines

enthalten in: Drug metabolism and personalized therapy | 2021

von Fedorinov, D. | Lyadov, V. | Sychev, D.

3

Genotype-based chemotherapy for patients with gastrointestinal tumors : focus on oxaliplatin, irinotecan, and fluoropyrimidines

enthalten in: Drug metabolism and personalized therapy | 2021

von Fedorinov, D. | Lyadov, V. | Sychev, D.

4

ADME pharmacogenetics : future outlook for Russia

enthalten in: Pharmacogenomics | 2019

von Mirzaev, K. | Fedorinov, D. | Ivashchenko, D. | +1

5

ADME pharmacogenetics: future outlook for Russia

enthalten in: Pharmacogenomics | 2019

von Mirzaev, K. | Fedorinov, D. | Ivashchenko, D. | +1

6

Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA)

enthalten in: Drug metabolism and personalized therapy | 2018

von Fedorinov, D. | Mirzaev, K. | Mustafina, V. | +6

7

Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA)

enthalten in: Drug metabolism and drug interactions | 2018

von Fedorinov, D. | Mirzaev, K. | Mustafina, V. | +6

8

Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA)

enthalten in: Drug metabolism and personalized therapy | 2018

von Fedorinov, D. | Mirzaev, K. | Mustafina, V. | +6

9

Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA)

enthalten in: Drug metabolism and drug interactions | 2018

von Fedorinov, D. | Mirzaev, K. | Mustafina, V. | +6

10

The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes

enthalten in: Drug metabolism and personalized therapy | 2018

von Mirzaev, K. | Rytkin, E. | Ryzhikova, K. | +8